Navigation Links
Lupus Research Institute: Benlysta(TM) Trial Results in an Historic Research Breakthrough and Victory for People With Lupus
Date:11/2/2009

Second successful phase III trial points to the first new lupus treatment in over 5O years.

NEW YORK, Nov. 2 /PRNewswire-USNewswire/ -- The Lupus Research Institute (LRI) and its National Coalition of state and local lupus organizations congratulate Human Genome Sciences (HGS) and GlaxoSmithKline for achieving an historical landmark - the second positive phase 3 clinical trial of Benlysta (belimumab), the first successfully tested new drug developed specifically for people with systemic lupus.

"This is a pivotal moment in lupus research," said Margaret G. Dowd, president of the LRI, an organization that pioneers discovery in lupus. "It demonstrates the power of innovative science to drive discovery and achieve solid clinical results in the complex autoimmune disease of lupus. Benlysta represents new hope for the 1.5 million Americans with lupus and millions more worldwide who have suffered without a safe and effective treatment for more than 50 years."

"This is spectacular news for the world-wide lupus community," said Tammy O. Utset, MD, MPH, an associate professor of medicine at the University of Chicago. "These trials demonstrate that SLE can be studied successfully in a clinical trial setting and should encourage further interest in drug development for lupus, an area of great unmet need. Further, these two large, well-designed trials will allow Benlysta, the first biological agent for the treatment of SLE, to be submitted to the FDA for potential approval."

The trial was the second double-blind, placebo-controlled, multi-center study of Benlysta. Known as BLISS-76, the trial enrolled and randomized 826 patients at 133 clinical sites in 19 countries, primarily in North America and Europe.

"Combining the results of this study with the previous successful BLISS-52 study will yield a very large dataset that will allow a better understanding of lupus, the instruments to measure lupus act
'/>"/>

SOURCE Lupus Research Institute
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. ZymoGenetics and Merck Serono Receive FDA Special Protocol Assessment for Atacicept Pivotal Study in Lupus Nephritis
2. Dynavax Reports Progress in Lupus Program With Inhibitor of TLR7 and TLR9
3. Trubion Pharmaceuticals, Inc. Announces Initiation of Phase 1 Study of SBI-087 for the Treatment of Systemic Lupus Erythematosus (SLE)
4. Human Genome Sciences Reports Positive Long-Term Data for BENLYSTA(TM) (Formerly LymphoStat-B(R)) in Patients With Active Systemic Lupus Erythematosus
5. Human Genome Sciences to Host July 20 Conference Call to Discuss Top-Line Phase 3 Results for Benlysta(TM) (Formerly Lymphostat-B(R)) in Systemic Lupus Erythematosus
6. Biologic Agents Will Drive the Systemic Lupus Erythematosus Drug Market to More Than Quadruple to Nearly $2 Billion in 2018
7. Promise of a New Lupus Treatment Is a Groundbreaking Achievement
8. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
9. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
10. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
11. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... Vycom announced today that Modutek ... chemical process equipment, has selected its Flametec materials for ... Rare Isotope Beams (FRIB). This involved the creation ... with Vycom’s Flametec PVC-C and Kytec PVDF material to ... of FRIB’s linear accelerator (known as LINAC). ...
(Date:8/26/2014)... YORK , Aug. 26, 2014  That,s Nice ... science markets, today announced the formation of a new ... content development. The expanded team will combine current and ... areas at That,s Nice. Guy ... Content to lead the team. Tiene was previously Director ...
(Date:8/26/2014)... Historically, drug development has faced a ... grow – high attrition rate, low productivity, patent ... regulatory hurdles and increasing concern about adverse ... the traditional business model of pharmaceutical companies is ... to find better ways to reduce operational costs ...
(Date:8/25/2014)... (PRWEB) August 26, 2014 Spirax ... steam systems, is excited to announce their latest training ... This five-day course is being held on December 15 ... in Blythewood, South Carolina where participants will learn virtually ... The training course is exclusively designed for Steam ...
Breaking Biology Technology:Modutek Selects Vycom’s Flametec Materials for Michigan State University’s Superconductor Equipment 2Modutek Selects Vycom’s Flametec Materials for Michigan State University’s Superconductor Equipment 3That's Nice Announces Expanded Offering For Strategic Content And Public Relations 2That's Nice Announces Expanded Offering For Strategic Content And Public Relations 3Transitioning from Bench into Clinical Phase, new webinar hosted by Xtalks 2Spirax Sarco's Basic Steam Boiler Operator Training Course Is Coming in December to South Carolina 2
... supports continued focus on rare disorders - , , ... today announced the receipt of two government grants to support ... of Defense Neurofibromatosis Research Program has awarded an $822,345 grant ... PTC,s product candidate PTC299 in neurofibromatosis type 2 (NF2), a ...
... NEW YORK and XIANYANG, China, ... Board: BSPM) ("Biostar" or "the,Company"), a leading manufacturer ... variety of diseases and conditions through its wholly,owned ... has retained HC,International to lead a strategic communications ...
... June 15 NeoStem, Inc. (NYSE Amex: ... and long-term storage of adult stem cells for future ... 10-year agreement with Enhance BioMedical Holdings Limited, a Shanghai ... Network using NeoStem,s proprietary adult stem cell technologies in ...
Cached Biology Technology:PTC Therapeutics Receives $2.6 Million in Government Grants 2PTC Therapeutics Receives $2.6 Million in Government Grants 3PTC Therapeutics Receives $2.6 Million in Government Grants 4Biostar Pharmaceuticals, Inc. Retains HC International, Inc. to Implement Investor Relations Program 2Biostar Pharmaceuticals, Inc. Retains HC International, Inc. to Implement Investor Relations Program 3Biostar Pharmaceuticals, Inc. Retains HC International, Inc. to Implement Investor Relations Program 4NeoStem Signs Agreement with Shanghai Corporation to Develop A Stem Cell Collection and Treatment Network in Shanghai, Taiwan and Other Targeted China Provinces 2NeoStem Signs Agreement with Shanghai Corporation to Develop A Stem Cell Collection and Treatment Network in Shanghai, Taiwan and Other Targeted China Provinces 3NeoStem Signs Agreement with Shanghai Corporation to Develop A Stem Cell Collection and Treatment Network in Shanghai, Taiwan and Other Targeted China Provinces 4
(Date:8/26/2014)... Zealand endemic tree has for the last 31 years been ... shrubs and small trees. A New Zealand botanist has completed ... cryptic diversity behind what was long considered a single tree ... PhytoKeys . , Known to botanists as ... many discoveries made in the north-western South Island of New ...
(Date:8/26/2014)... as global warming and poverty the result of ... on our failure as consumers to make better ... the Journal of Consumer Research , responsible ... from governments to consumers and ultimately benefits corporations ... to encourage responsible consumption instead of implementing policy ...
(Date:8/26/2014)... CHAMPAIGN, Ill. A new analysis suggests the planet ... material in leaves, stems, roots, fruits, grains and other ... study , reported in Environmental Science and ... productivity, and finds that it is much higher than ... estimate something over the whole planet, you have to ...
Breaking Biology News(10 mins):And then there were 10 -- unexpected diversity in New Zealand kanuka genus Kunzea 2And then there were 10 -- unexpected diversity in New Zealand kanuka genus Kunzea 3An inconvenient truth: Does responsible consumption benefit corporations more than society? 2Study: Earth can sustain more terrestrial plant growth than previously thought 2Study: Earth can sustain more terrestrial plant growth than previously thought 3
... wizards of camouflage. Adept at blending in with their ... of body patterns and can switch between them almost ... appear in the May 2006 issue of the journal ... change their appearance based on visual cues, they do ...
... Medical Center have demonstrated systemic spread of avian influenza ... contact. The paper by Rimmelzwaan et al., "Influenza ... with potential novel routes of virus spread within and ... American Journal of Pathology and is accompanied by a ...
... but hardy, unblemished skin and slow developing gills appear ... notothenioids, a group of fish whose adults thrive in ... blood. , Such adaptations are important, researchers at the ... of at least two species of notothenioids that inhabit ...
Cached Biology News:Cuttlefish masters of disguise despite colorblindness 2Avian influenza virus in mammals spreads beyond the site of infection to other organ systems 2Thin tough skin, slow-growing gills protect larval Antarctic fish 2Thin tough skin, slow-growing gills protect larval Antarctic fish 3
...
Rabbit polyclonal to XTP4 ( Abpromise for all tested applications). entrezGeneID: 84299 SwissProtID: Q9BRT3...
...
Sold individually or included in the MasterAmp™ PCR Optimization Kit without ammonium sulfate. Includes dNTPs, buffer, and varying amounts of MgCl2 and the MasterAmp™ PCR Enhancer (with be...
Biology Products: